Featured High-Throughput Sequencing Products
Explore our leading genomics and molecular biology solutions designed to power multi-omics integration and metabolic discovery.
The Landscape of Metabolic Profiling in Japan
Metabolic profiling, or metabolomics, has emerged as a cornerstone of functional genomics and precision medicine in Japan. As the country faces the challenges of a super-aging society, both academic institutions and commercial enterprises are heavily investing in technology that deciphers the relationship between genetics, environment, diet, and disease. By analyzing low-molecular-weight metabolites, Japanese researchers are establishing direct links between genotypes and phenotypes, paving the way for personalized preventative healthcare.
In the commercial sector, metabolic profiling is widely utilized across the pharmaceutical, functional food, and agricultural industries. Key industrial hubs in Tokyo, Osaka, and Kanagawa host world-class biotechnology companies specializing in mass spectrometry (MS) and nuclear magnetic resonance (NMR) analytics. These companies work closely with academic pioneers, such as Keio University’s Institute for Advanced Biosciences and the RIKEN Center for Integrative Medical Sciences, to create robust biomarker pipelines for early diagnosis of metabolic syndrome, neurodegenerative disorders, and cancer.
The modern Japanese biotech market is rapidly moving away from single-omics studies. The integration of high-throughput sequencing (NGS) data with metabolic profiling—known as multi-omics—has become the standard approach for drug discovery, clinical biomarker validation, and gut microbiome research.
Localized Application Scenarios in Japan
The application of metabolic profiling in Japan is highly tailored to the nation's unique cultural, dietary, and economic factors. Three primary areas stand out as key drivers of the local metabolomics market:
1. Preventative Healthcare & Longevity
With one of the highest life expectancies globally, Japan focuses intensely on "healthy longevity." Metabolic profiling of large clinical cohorts helps identify pre-symptomatic biomarkers for age-related conditions, allowing for targeted nutritional and lifestyle interventions before chronic diseases manifest.
2. Functional Food (FOSHU) Development
Japan is the pioneer of Foods for Specified Health Uses (FOSHU). Food and beverage conglomerates utilize metabolomics to scientifically validate the health claims of functional ingredients, mapping out how local products like green tea catechins or fermented foods interact with human metabolic pathways.
3. Kampo Medicine Standardization
Traditional Japanese Kampo medicine relies on complex herbal formulations. Metabolic profiling provides a scientific framework to standardize these natural remedies, ensuring batch-to-batch consistency and identifying the active synergistic compounds to satisfy modern pharmaceutical regulations.
Furthermore, Japan's agricultural sector leverages metabolic profiling to optimize crop breeding and food quality. For instance, the metabolic signature of high-grade Wagyu beef, premium sake, and regional agricultural products is analyzed to ensure authenticity, trace origins, and improve taste profiles. This intersection of traditional industries with cutting-edge multi-omics technologies highlights the versatile future of metabolomics services in the Japanese market.
Biomarker Technologies (BMKGene)
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
By combining state-of-the-art sequencing hardware with self-developed bioinformatics clouds, BMKGene empowers researchers in Japan and globally to bridge molecular data with biological insights, offering seamless integration from sample extraction to publication-ready figures.
Our Sequencing & Analytical Platforms
We host an array of advanced instruments to support diverse experimental designs and high-throughput research goals.
Long-Read Sequencing Platforms
PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5, MinION
Short-Read & Single-Cell Platforms
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Mass Spec & Physical Mapping
Waters XEVO G2-XS QTOF
QTRAP 6500+
Bionano Irys system
Fully Automated Platform for Next-Generation Sequencing
Brilliant Lab 1000 (BL1000)
Biomarker technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.
BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services.
Enterprise Qualification & Certifications
Our commitment to quality is backed by globally recognized certifications, joint academic laboratories, and international research workstations.
Our Complete Product Portfolio
Explore our full selection of sequencing and genomics services optimized for global life science research.
For inquiries about our products or pricelist, please leave your email to us.
We will be in touch within 24 hours.
Inquiry Now
